ViaDerma Inc (VDRM)

[retired early]

The Company expects to begin the distribution of the final topical antibiotic product in the next few weeks. In order to assure, and maintain the highest level of "Quality Control", of the product, the first run has to undergo the most stringent testing. ViaDerma, Inc., feels the short delay is necessary to assure a smooth distribution process in the U.S. and abroad, as we will be selling the product in several countries around the Globe.
About ViaDerma, Inc. :)